Beloranib is a fumagillin anticancer drug that belongs to an angiogenesis inhibitor. References: Fujioka K. Current and emerging medications for overweight or obesity in people with comorbidities. Diabetes Obes Metab. 2015 Nov;17(11):1021-32. doi: 10.1111/dom.12502. Epub 2015 Jul 8. Review. PubMed PMID: 26040215; PubMed Central PMCID: PMC4744746.

纯度：≥98%

CAS：251111-30-5